Children 6 35 mo may receive any of the following IIV3 or ccIIV3 products Preferred site is anterolateral aspect of thigh

By rray, 12 September, 2023
Exclude Patient Type Detail Header
No
Detail Type
Text
Patient Type Detail Header (Long)
Children 6-35 mo may receive any of the following IIV3 or ccIIV3 products. Preferred site is anterolateral aspect of thigh.